Comprehensive Metabolic Profiling Assessed for Chronic Inflammation
By LabMedica International staff writers Posted on 08 Jan 2018 |
Image: The BCS XP System, one of the most widely used fully automated hemostasis analyzers (Photo courtesy of Siemens Healthineers).
Inflammation is a corporeal response to damaging stimuli associated with the activation of various molecular mechanisms. Both the local and systemic responses initiated by an inflammatory process indicate an imbalance in metabolism in the tissues affected.
Inflammation occurs as an immediate protective response of the immune system to a harmful stimulus, whether locally confined or systemic. In contrast, a persisting chronic, inflammatory state, even at a low-grade, is a well-known risk factor in the development of common diseases like diabetes or atherosclerosis.
Scientists at the University Medicine Greifswald (Greifswald, Germany) assessed the metabolic patterns associated with alterations in inflammatory markers. Based on mass spectrometry and nuclear magnetic resonance spectroscopy they determined a comprehensive panel of 613 plasma and 587 urine metabolites among 925 apparently healthy individuals. Associations between inflammatory markers, namely high-sensitivity C-reactive protein (hsCRP), white blood cell counts (WBC), and fibrinogen, and metabolite levels were tested by linear regression analyses controlling for common confounders.
Fibrinogen concentrations were determined in citrate plasma samples, using a BCS-XP system. WBC concentration was determined in EDTA whole blood samples using the Sysmex XT 2000, XE 5000, or SE9000 analyzers or the Siemens Healthcare Diagnostics Advia 2120i. Targeted metabolomics profiling of the plasma samples was performed using the AbsoluteIDQ p180 Kit.
This approach allows simultaneous absolute quantification of 188 metabolites using a combination of liquid chromatography and mass spectrometry. Urine samples were measured on a Bruker DRX-400 NMR Spectrometer.
The team found that HsCRP, WBC, and fibrinogen were significantly associated with 71, 20, and 19 plasma and 22, 3, and 16 urine metabolites, respectively. Identified metabolites were related to the bradykinin system, involved in oxidative stress (e.g., glutamine or pipecolate) or linked to the urea cycle (e.g., ornithine or citrulline). In particular, urine 3’-sialyllactose was found as a novel metabolite related to inflammation. Prediction of an advanced inflammatory state based solely on 10 metabolites was completely feasible. The study was published on November 30, 2017, in the journal BMC Medicine.
Related Links:
University Medicine Greifswald
Inflammation occurs as an immediate protective response of the immune system to a harmful stimulus, whether locally confined or systemic. In contrast, a persisting chronic, inflammatory state, even at a low-grade, is a well-known risk factor in the development of common diseases like diabetes or atherosclerosis.
Scientists at the University Medicine Greifswald (Greifswald, Germany) assessed the metabolic patterns associated with alterations in inflammatory markers. Based on mass spectrometry and nuclear magnetic resonance spectroscopy they determined a comprehensive panel of 613 plasma and 587 urine metabolites among 925 apparently healthy individuals. Associations between inflammatory markers, namely high-sensitivity C-reactive protein (hsCRP), white blood cell counts (WBC), and fibrinogen, and metabolite levels were tested by linear regression analyses controlling for common confounders.
Fibrinogen concentrations were determined in citrate plasma samples, using a BCS-XP system. WBC concentration was determined in EDTA whole blood samples using the Sysmex XT 2000, XE 5000, or SE9000 analyzers or the Siemens Healthcare Diagnostics Advia 2120i. Targeted metabolomics profiling of the plasma samples was performed using the AbsoluteIDQ p180 Kit.
This approach allows simultaneous absolute quantification of 188 metabolites using a combination of liquid chromatography and mass spectrometry. Urine samples were measured on a Bruker DRX-400 NMR Spectrometer.
The team found that HsCRP, WBC, and fibrinogen were significantly associated with 71, 20, and 19 plasma and 22, 3, and 16 urine metabolites, respectively. Identified metabolites were related to the bradykinin system, involved in oxidative stress (e.g., glutamine or pipecolate) or linked to the urea cycle (e.g., ornithine or citrulline). In particular, urine 3’-sialyllactose was found as a novel metabolite related to inflammation. Prediction of an advanced inflammatory state based solely on 10 metabolites was completely feasible. The study was published on November 30, 2017, in the journal BMC Medicine.
Related Links:
University Medicine Greifswald
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines